# Cochlear / Oticon merger inquiry
The CMA investigated the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
From:[Competition and Markets Authority](/government/organisations/competition-and-markets-authority)Published11 October 2022Last updated
29 May 2024
— [See all updates](#full-publication-update-history)
Case type:[Mergers](/cma-cases?case_type%5B%5D=mergers)Case state:[Closed](/cma-cases?case_state%5B%5D=closed)Market sector:[Healthcare and medical equipment](/cma-cases?market_sector%5B%5D=healthcare-and-medical-equipment)Outcome:[Mergers - phase 2 clearance with remedies](/cma-cases?outcome_type%5B%5D=mergers-phase-2-clearance-with-remedies)Opened:
11 October 2022
Closed:
29 May 2024
## Phase 2
### Administrative timetable
Referral date: 20 December 2022
Statutory deadline: 31 July 2023
- [Administrative timetable (PDF, 103KB)](https://assets.publishing.service.gov.uk/media/6464b14ed3231e000c32daee/Administrative_timetable_.pdf) (18.5.23)
### Contact
[general.enquiries@cma.gov.uk](mailto:general.enquiries@cma.gov.uk)
### Case closure summary
29 May 2024: On 17 May 2024, pursuant to final undertakings that it accepted from Cochlear and Demant, the CMA approved the sale of Demant’s cochlear implants business to Cochlear. This brings the merger investigation to a close.
- [Case closure summary (PDF, 94KB)](https://assets.publishing.service.gov.uk/media/66570cbe7b792ffff71a84b2/Case_closure_summary__1_.pdf) (29.5.24)
### Remedy Group appointed
24 August 2023: The CMA has appointed the Remedy Group.
Kip Meek (Chair), Anne Fletcher, Keith Richards and David Thomas.
### Final undertakings
24 August 2023: The CMA has accepted final undertakings and the reference has now been fully determined.
- [Notice to accept final undertakings (PDF, 138 KB)](https://assets.publishing.service.gov.uk/media/64ee4709da845100146323c2/Notice_to_accept_final_undertakings_pdfa2.pdf) (30.8.23)
- [Final undertakings (PDF, 245KB)](https://assets.publishing.service.gov.uk/media/64ef05b86bc96d000d4ed294/Final_Undertakings_take_4_PDFA.pdf) (30.8.23)
### Notice of proposal to accept final undertakings
2 August 2023: The CMA gives notice of the proposal to accept final undertakings and is inviting comments on the proposed draft undertakings by 5pm on 16 August 2023.
- [Notice of proposal to accept final undertakings (PDF, 142KB)](https://assets.publishing.service.gov.uk/media/64c8d0f75c2e6f0013e8d816/A._Notice_of_proposal_to_accept_final_undertakings.pdf) (2.8.23)
- [Draft final undertakings (PDF, 229KB)](https://assets.publishing.service.gov.uk/media/64c8d11019f562000df3c1a5/A-_Final_undertakings_for_Cochlear_and_Demant.pdf) (2.8.23)
### Final report
22 June 2023: The CMA has published its final report.
- [Final Report (PDF, 1.16 MB)](https://assets.publishing.service.gov.uk/media/64942fb79e7a8b00139329b8/A._Final_report.pdf) (22.6.23)
- [Appendices and glossary (PDF, 438 KB)](https://assets.publishing.service.gov.uk/media/64943095de8682000cbc8c46/1._Appendices_and_Glossary.pdf) (22.6.23)
- [Summary of final report (PDF, 158KB)](https://assets.publishing.service.gov.uk/media/64930a1e5f7bb700127fae51/Summary.pdf) (22.6.23)
- Press Notice: [CMA action protects outcomes for hearing implant patients](https://www.gov.uk/government/news/cma-action-protects-outcomes-for-hearing-implant-patients) (22.6.23)
### Notice of extension of statutory period
- [Notice of extension (PDF, 102KB)](https://assets.publishing.service.gov.uk/media/6464b218d3231e001332daf2/Notice_of_extension_.pdf) (18.5.23)
### Responses to provisional findings and possible remedies
- [Cochlear’s response to the provisional findings (176KB)](https://assets.publishing.service.gov.uk/media/6464b2660b72d3000c344607/Cochlear_response_to_PFs_.pdf) (18.5.23)
- [Cochlear’s response to the notice of possible remedies (PDF, 165KB)](https://assets.publishing.service.gov.uk/media/645e05cbad8a03000c38b377/Cochlear_Response_to_Notice_of_Possible_Remedies.pdf) 12.5.23)
- [Demant’s response to the notice of possible remedies (PDF, 238KB)](https://assets.publishing.service.gov.uk/media/645e0608ad8a03000c38b379/Demant_Response_to_Notice_of_Possible_Remedies.pdf) (12.5.23)
- [University Hospitals Plymouth NHS Trust’s response to the notice of possible remedies (PDF, 125KB)](https://assets.publishing.service.gov.uk/media/645e0637ad8a03001138b362/University_Hospitals_Plymouth_NHS_Trust_response_to_provisional_findings_.pdf) (12.5.23)
### Provisional findings
20 April 2023: The CMA has provisionally found competition concerns as part of its in-depth investigation of the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
The deadline for submitting responses to the provisional findings is Thursday 11 May 2023.
The deadline for submitting responses to the notice of possible remedies is Thursday 4 May 2023.
- [Summary of provisional findings (PDF, 148KB)](https://assets.publishing.service.gov.uk/media/644042aa6dda69000c11e14a/Summary_of_provisional_findings.pdf) (20.4.23)
- [Notice of provisional findings (PDF, 144KB)](https://assets.publishing.service.gov.uk/media/644042956dda69000c11e149/Notice_of_provisional_findings.pdf) (20.4.23)
- [Notice of possible remedies (PDF, 219KB)](https://assets.publishing.service.gov.uk/media/6440427c8b86bb0013f1b602/Notice_of_possible_remedies.pdf) (20.4.23)
- [Provisional findings (PDF, 924 KB)](https://assets.publishing.service.gov.uk/media/644150916dda69000c11e1e6/Cochlear_Oticon_provisional_report.pdf) (20.4.23)
- [Appendices and glossary (PDF, 820KB)](https://assets.publishing.service.gov.uk/media/64414f2b6dda69000c11e1e3/Appendices_and_glossary.pdf) (20.4.23)
- Press Notice: [Hearing implants deal could mean worse outcomes for patients](https://www.gov.uk/government/news/hearing-implants-deal-could-mean-worse-outcomes-for-patients) (20.4.23)
### Responses to the issues statement
- [Parties joint response (PDF, 1,015KB)](https://assets.publishing.service.gov.uk/media/6419d23bd3bf7f7ffc140271/A._Parties_joint_response.pdf) (21.3.23)
- [University Hospitals Sussex NHS Foundation Trust (PDF, 136KB)](https://assets.publishing.service.gov.uk/media/6411ba91d3bf7f79e2613cf5/University_Hospitals_Sussex_NHS_Foundation_Trust_.pdf) (20.3.23)
### Issues statement
20 January 2023: The issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions. The deadline for submissions on the issues statement is 5pm, 3 February 2023.
- [Issues statement (PDF, 213KB)](https://assets.publishing.service.gov.uk/media/63c9397a8fa8f51c8961a860/Cochlear-Oticon_Issues_Statement__.pdf) (20.1.23)
### Inquiry group appointed
21 December 2022: The CMA has appointed the inquiry group.
[Kip Meek](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/inquiry-chairs-biographies#kip-meek) (Chair), [Anne Fletcher](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#anne-fletcher), [Keith Richards](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#keith-richards) and [David Thomas](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#david-thomas).
### Terms of reference
20 December 2022: The CMA has referred the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical, for an in-depth investigation.
- [Terms of reference (PDF, 101KB)](https://assets.publishing.service.gov.uk/media/63a07a4ee90e07587bd8ba66/Cochlear_-_Oticon_-_Terms_of_Reference.pdf) (20.12.22)
## Statutory timetable
| Phase 1 | Action |
| --- | --- |
| 6 December 2022 | Phase 1 decision announced |
| 14 November 2022 | Initial enforcement order |
| 11 October 2022 to 25 October 2022 | Invitation to comment |
| 11 October 2022 | Launch of merger inquiry |
## Phase 1
### Reference decision
20 December 2022: The CMA has referred the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical, for an in-depth investigation, on the basis that, on the information currently available to it, it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom.
- [Decision to refer (PDF, 106KB)](https://assets.publishing.service.gov.uk/media/63a07a6c8fa8f539153653ef/Cochlear_-_Oticon_-_Decision_to_refer.pdf) (20.12.22)
### Reference unless undertakings accepted
6 December 2022: The CMA has decided, on the information currently available to it, that it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. This merger will be referred for a phase 2 investigation unless the parties offer acceptable undertakings to address these competition concerns.
- [Full text decision (PDF, 547KB)](https://assets.publishing.service.gov.uk/media/63c939178fa8f51c8961a85f/Cochlear_Oticon_fulltext_decision_.pdf) (20.1.23)
- [Summary of phase 1 decision (PDF, 112KB)](https://assets.publishing.service.gov.uk/media/638e18dfd3bf7f327f4c7090/Cochlear_-_Oticon_-_Decision_Summary.pdf) (6.12.22)
- Press release: [Hearing implants merger could mean worse deal for NHS and patients](https://www.gov.uk/government/news/hearing-implants-merger-could-mean-worse-deal-for-nhs-and-patients) (6.12.22)
### Initial enforcement order
14 November 2022: The CMA served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on Demant A/S and its Oticon Medical subsidiaries, in relation to the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
- [Initial enforcement order](https://assets.publishing.service.gov.uk/media/63760512e90e0728495496fd/Initial_enforcement_order.pdf) (17.11.22)
### Amendments/consents granted:
- [Derogation 11 August 2023 (PDF, 131KB)](https://assets.publishing.service.gov.uk/media/64df360d3fde61000d4a547b/Derogation_11_August_2023.pdf) (18.8.23)
- [Derogation 20 June 2023 (PDF, 116KB)](https://assets.publishing.service.gov.uk/media/64ad35d3c933c1000cf9e0dd/Derogation_20_June_2023_PDFA__115_KB_.pdf) (11.7.23)
- [Derogation 19 June 2023 (PDF, 117KB)](https://assets.publishing.service.gov.uk/media/64ad3829c933c1000cf9e0e0/Derogation_19_June_2023__115_KB_.pdf) (11.7.23)
- [Derogation 31 May 2023 (PDF, 115KB)](https://assets.publishing.service.gov.uk/media/6481b14d5f7bb7000c7fa6f0/A._Derogation_30_May_2023.pdf) (8.6.23)
- [Derogation 18 May 2023 (PDF, 115KB)](https://assets.publishing.service.gov.uk/media/646dc783382a51000c9fc664/Derogation_18_May_2023.pdf) (24.5.23)
- [Derogation 3 May 2023 (PDF, 121KB)](https://assets.publishing.service.gov.uk/media/645b55fec6e897000ca0fbf7/Derogation_3_May_2023.pdf) (10.5.23)
- [Derogation 20 April 2023 (PDF, 116KB)](https://assets.publishing.service.gov.uk/media/6450c491c33b46000cf5e4fd/Derogation_20_April_2023.pdf) (2.5.23)
- [Derogation 17 March 2023 (PDF, 122KB)](https://assets.publishing.service.gov.uk/media/6421437c5155a200136ad73d/Cochlear_Oticon_-_consent_letter_-_Retirement_derogation.pdf) (27.3.23)
- [Derogation 14 February 2023 (PDF, 131KB)](https://assets.publishing.service.gov.uk/media/6401be538fa8f527f110a391/Cochlear_oticon_Publication_version_consent_letter.pdf) (3.3.23)
- [Derogation 7 February 2023 (PDF, 211KB)](https://assets.publishing.service.gov.uk/media/63f775d2d3bf7f25ed3f5762/Cochlear_Oticon_derogation_7_FEB_US_change_of_reporting.pdf) (24.2.23)
- [Derogation 6 February 2023 (PDF, 177KB)](https://assets.publishing.service.gov.uk/media/63f775acd3bf7f25efc1c25e/Cochlear_Oticon_derogation_6_FEB_2023.pdf) (24.2.23)
- [Derogation 13 January 2023 (PDF, 158KB)](https://assets.publishing.service.gov.uk/media/63e22991d3bf7f172ccae137/Cochlear_Oticon_derogation_letter_13_January_2023_.pdf) (8.2.23)
- [Derogation 4 January 2023 (PDF, 136KB)](https://assets.publishing.service.gov.uk/media/63e2296c8fa8f50e8b8984a9/Cochlear_Oticon_derogation_letter_4_January_2023_.pdf) (8.2.23)
- [Derogation 23 December 2022 (PDF, 144KB)](https://assets.publishing.service.gov.uk/media/63ac59b0d3bf7f7c13cf4603/Derogation_28_Dec_2022_Cochlear_Oticon.pdf) (29.12.22)
- [Derogation 7 December 2022 (PDF, 158 KB)](https://assets.publishing.service.gov.uk/media/6399b64ce90e072ae6097137/Cochlear_Oticon_FOR_PUBLICATION_consent_letter_Ponto.pdf) (14.12.22)
- [Derogation 29 November 2022 (PDF, 135 KB)](https://assets.publishing.service.gov.uk/media/63889007d3bf7f328c0ded1e/Cochlear_Oticon_FINAL_consent_letter.pdf) (1.12.22)
- [Derogation 14 November 2022 (PDF, 154KB)](https://assets.publishing.service.gov.uk/media/63760526d3bf7f7209bf2d96/deleteDerogation_14_November_2022.pdf) (17.11.22)
### Launch merger inquiry
11 October 2022: The CMA announced the launch of its merger inquiry by notice to the parties.
- [Commencement notice](https://assets.publishing.service.gov.uk/media/6344238fd3bf7f58733e2c8e/Cochlear_-_Oticon_-_Commencement_Notice__-.pdf) (11.10.22)
### Invitation to comment: Now closed
11 October 2022: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invited comments on the transaction from any interested party.
## Updates to this page
Published 11 October 2022
Last updated 29 May 2024
[+ show all updates](#full-history)
01. 29 May 2024
Case closed
02. 30 August 2023
Notice to accept final undertakings and Final undertakings published
03. 18 August 2023
Derogation published
04. 2 August 2023
Notice of proposal to accept final undertakings published.
05. 11 July 2023
Derogations published.
06. 22 June 2023
Full text, appendices and glossary published.
07. 24 May 2023
Derogation published.
08. 18 May 2023
Statutory deadline extended, administrative timetable, notice of extension and Cochlear’s response to the provisional findings published.
09. 12 May 2023
Responses to possible remedies published.
10. 10 May 2023
Derogation published.
11. 2 May 2023
Derogation published.
12. 20 April 2023
Full provisional findings report, appendices and glossary published.
13. 20 April 2023
Summary of provisional findings, notice of possible remedies and notice of provisional findings published.
14. 27 March 2023
Derogation published.
15. 20 March 2023
Responses to issues statement published.
16. 3 March 2023
Derogation published.
17. 24 February 2023
Derogations published.
18. 8 February 2023
Derogations published.
19. 20 January 2023
Issues statement, administrative timetable and phase 1 full text decision published.
20. 29 December 2022
Derogation published
21. 21 December 2022
Inquiry group appointed.
22. 20 December 2022
Decision to refer, terms of reference and administrative timetable published.
23. 14 December 2022
Derogation published.
24. 6 December 2022
Summary of phase 1 decision published.
25. 1 December 2022
Derogation published
26. 17 November 2022
Initial enforcement order and derogation published.
27. 11 October 2022
First published.
[Contents](#contents)